Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Narikazu Boku

Showing results (1-10 of 436) with videos related to

Pageof 44
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|May 25, 2010
Emerging treatment with systemic chemotherapy and targeted agents for biliary cancersNarikazu Boku
Discovery Medicine|March 3, 2010
Perspectives for personalization in chemotherapy of advanced gastric cancerNarikazu Boku
Japanese Journal of Clinical Oncology|October 8, 2011
Past and present achievements, and future direction of the Gastrointestinal Oncology Study Group (GIOSG), a Division of Japan Clinical Oncology Group (JCOG)Narikazu Boku
Japanese Journal of Clinical Oncology|January 6, 2010
Current status and problems in development of molecular target agents for gastrointestinal malignancy in JapanNarikazu Boku
International Journal of Clinical Oncology|June 17, 2008
Chemotherapy for metastatic disease: review from JCOG trialsNarikazu Boku,
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 9, 2013
HER2-positive gastric cancerNarikazu Boku
International Journal of Clinical Oncology|December 19, 2008
Chemotherapy for metastatic gastric cancer in JapanNarikazu Boku
Clinical Colorectal Cancer|August 29, 2018
Selection of Second-line Anti-angiogenic Agents After Failure of Bevacizumab-containing First-line Chemotherapy in Metastatic Colorectal CancerNarikazu Boku, Shun Yamamoto
Asia-Pacific Journal of Clinical Oncology|June 7, 2018
The current status of multimodality treatment for unresectable locally advanced esophageal squamous cell carcinomaHidekazu Hirano, Narikazu Boku
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 21, 2012
[A guideline for antimetics use for patients with malignancies]Yoshiki Horie, Narikazu Boku
Pageof 44

Showing results (1-10 of 436) with videos related to

Sort By:
Pageof 44
Current Opinion in Investigational Drugs (London, England : 2000)|May 25, 2010
Emerging treatment with systemic chemotherapy and targeted agents for biliary cancersNarikazu Boku
Discovery Medicine|March 3, 2010
Perspectives for personalization in chemotherapy of advanced gastric cancerNarikazu Boku
Japanese Journal of Clinical Oncology|October 8, 2011
Past and present achievements, and future direction of the Gastrointestinal Oncology Study Group (GIOSG), a Division of Japan Clinical Oncology Group (JCOG)Narikazu Boku
Japanese Journal of Clinical Oncology|January 6, 2010
Current status and problems in development of molecular target agents for gastrointestinal malignancy in JapanNarikazu Boku
International Journal of Clinical Oncology|June 17, 2008
Chemotherapy for metastatic disease: review from JCOG trialsNarikazu Boku,
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 9, 2013
HER2-positive gastric cancerNarikazu Boku
International Journal of Clinical Oncology|December 19, 2008
Chemotherapy for metastatic gastric cancer in JapanNarikazu Boku
Clinical Colorectal Cancer|August 29, 2018
Selection of Second-line Anti-angiogenic Agents After Failure of Bevacizumab-containing First-line Chemotherapy in Metastatic Colorectal CancerNarikazu Boku, Shun Yamamoto
Asia-Pacific Journal of Clinical Oncology|June 7, 2018
The current status of multimodality treatment for unresectable locally advanced esophageal squamous cell carcinomaHidekazu Hirano, Narikazu Boku
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 21, 2012
[A guideline for antimetics use for patients with malignancies]Yoshiki Horie, Narikazu Boku
Pageof 44